Collaborates with the research of the Parc Taulí Research and Innovation Institute
With your donation we will be able to promote research and innovation projects to advance the development of new treatments that improve patients' well-being and quality of life.
Know the projects
Minority diseases
It supports the research of diseases with low prevalence in our society.
Most of these diseases are of genetic origin, highly complex and appear in early childhood. Parc Taulí is a benchmark in its diagnosis and treatment.
Specifically, in the case of Prader Willi syndrome, Angelman syndrome and Fragile X syndrome, your contribution helps fund research that improves diagnoses and treatments, and improves patients' quality of life.
Learn about the projects that are being carried out in this area
Personalized and precision medicine in rheumatic diseases
The aim of the project is to identify substances in the body (biomarkers) that allow us to classify, group and treat each patient specifically with the aim of offering personalized and precision medicine in rheumatic diseases. Likewise, the influence of diet on these diseases and the general osteo-articular health of the individual is also assessed.
Study of sleep disorders and alterations chronobiological of the sleep/wake rhythm in children and adolescents with Angelman's syndrome
This project studies the prevalence of the main sleep disorders in children with Angelman syndrome, with a particular focus on circadian rhythm disorders. Its aim is to improve the quality of life of patients and their families.
The project will allow to determine the clinical improvement associated with the modification of behavioral factors and the administration of melatonin in a second clinical evaluation.
Diagnosis genomic depth in minority diseases
The project focuses on identifying genes that have undergone mutations that are only present in some cells of the body, but not in all. This will help improve the diagnosis of diseases, discover new genes related to these diseases, find potential targeted treatments and evaluate personalized treatment options for each patient.
Critical Patient
Contributing to research in critical and urgent care is critical to improving outcomes and survival in medical crisis situations. Donations in this area enable the development of precision diagnostics in real time, guaranteeing a quick and accurate response to critical conditions.
Learn about the projects that are currently being carried out in this area
Characterization, handling i prevented of them sequels post-ICU
Post-Intensive Care Syndrome is a set of symptoms that can appear in patients who have been admitted to the ICU. They can be physical, emotional or affect the person's memory and attention. Your donation will help design new follow-ups and treatments that can improve the quality of life for these people.
Chronic disease
By funding research into precision diagnostics, the detection and treatment of diseases such as cancer, autoimmune diseases and diabetes can be improved, enabling a more personalized and effective approach to patient health.
Find out about the projects we are currently carrying out in this area
advancing Postal Code to a medicine personalized en els disorders psychotic
The project of our research group focuses on the study of factors that allow predicting the therapeutic response and tolerance of patients to different antipsychotic drugs to avoid the discomfort they can generate.
Study from biopsy liquid in blood With a tool de diagnosis for improve la quality Life Insurance partly patients with glioma
This project aims to test whether the liquid biopsy protocol, which is a less invasive technique than traditional biopsies, is useful for diagnosing the most common brain tumors, gliomas. This is why we will compare the genetic mutations of the tumor cells released in the patients' plasma, with those present in the tumor tissue samples
Innovation en diagnosis i handling of the patient en hemodialysis
The aim of the project is to innovate in the diagnosis and management of hemodialysis patients to improve their quality of life and clinical outcomes. This innovation may include the development of new technologies, advanced monitoring techniques, personalized treatment protocols, and comprehensive management strategies that optimize treatment efficacy and reduce complications associated with hemodialysis.